Developing AAV1-hOTOF Gene Therapy for Autosomal Recessive Deafness 9
AAV1-hOTOF gene therapy is an experimental molecular treatment developed for Autosomal Recessive Deafness 9 (DFNB9), a form of congenital, prelingual, severe-to-profound hearing loss caused by […]